In addition, given the complex interplay between PI3K/Akt and JNK pathways in cancer and the proposed role of JNK in priming Akt activity in GBM response to therapy, the possible mutual interaction between these pathways in our experimental conditions should not be excluded [8,16]. This evidence concerns the gene AKT1 and cancer.